Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Consolidated Net Income: 2018-2024

Historic Consolidated Net Income for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$56.5 million.

  • Gossamer Bio's Consolidated Net Income fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.2 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
  • As of FY2024, Gossamer Bio's Consolidated Net Income stood at -$56.5 million, which was up 68.56% from -$179.8 million recorded in FY2023.
  • Gossamer Bio's Consolidated Net Income's 5-year high stood at -$56.5 million during FY2024, with a 5-year trough of -$243.2 million in FY2020.
  • Moreover, its 3-year median value for Consolidated Net Income was -$179.8 million (2023), whereas its average is -$155.2 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 33.24% in 2020, then surged by 68.56% in 2024.
  • Yearly analysis of 5 years shows Gossamer Bio's Consolidated Net Income stood at -$243.2 million in 2020, then grew by 3.45% to -$234.8 million in 2021, then grew by 2.31% to -$229.4 million in 2022, then rose by 21.61% to -$179.8 million in 2023, then soared by 68.56% to -$56.5 million in 2024.